Related Experiment Video
Updated: Dec 18, 2025
06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.9K
"LRRK2: Autophagy and Lysosomal Activity".
Marta Madureira1,2, Natalie Connor-Robson1, Richard Wade-Martins1
1Department of Physiology, Anatomy and Genetics, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Frontiers in Neuroscience
|June 12, 2020
Summary
Leucine-rich repeat kinase 2 (LRRK2) mutations are a common cause of Parkinson's disease (PD). This review explores LRRK2's role in neuronal autophagy and lysosomal function, crucial for PD pathogenesis and potential therapies.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Leucine-rich repeat kinase 2 (LRRK2) mutations are the most frequent genetic cause of Parkinson's disease (PD).
- LRRK2 protein is implicated in neuronal autophagy and lysosomal activity, processes vital for cellular health.
- Age-related decline in lysosomal function can exacerbate α-synuclein accumulation, a hallmark of PD.
Purpose of the Study:
- To review the physiological role of LRRK2 in the autophagy pathway within neurons.
- To elucidate LRRK2's specific functions in regulating autophagy, including vesicle formation, fusion, and lysosomal degradation.
- To discuss the implications of LRRK2's role in autophagy for Parkinson's disease pathogenesis and therapeutic strategies.
Main Methods:
- Comprehensive literature review of studies investigating LRRK2 function in autophagy and lysosomal pathways.
- Analysis of various LRRK2 models to understand conflicting phenotypes reported in the literature.
- Assessment of LRRK2's involvement in key steps of the autophagy-lysosomal pathway.
Main Results:
- LRRK2 plays a critical role in regulating multiple stages of autophagy, from phagophore formation to lysosomal degradation.
- Specific LRRK2 mutations (G2019S and R1441C) differentially affect kinase and GTPase activity, impacting autophagy.
- Dysregulation of LRRK2-mediated autophagy contributes to the accumulation of pathological proteins in Parkinson's disease.
Conclusions:
- Understanding LRRK2's precise role in neuronal autophagy is essential for deciphering Parkinson's disease mechanisms.
- Targeting LRRK2 and the autophagy pathway offers promising therapeutic avenues for restoring lysosomal homeostasis in PD.
- Further research into different LRRK2 models is needed to reconcile conflicting findings and guide therapeutic development.
Related Concept Videos
01:22Lysosomal Hydrolases
4.3K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.3K
01:36Delivery Pathways to the Lysosome
8.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.6K
01:27Autophagy
5.5K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
01:18Autophagic Cell Death
4.2K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K
01:32Export of Misfolded Proteins out of the ER
4.8K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.8K